The drug-coated balloon catheter system is being compared with a sham device in a double-blinded randomized trial.
Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm
Advertisement
Articles by Jason M. Broderick and Cheryl Guttman Krader, BS, Pharm
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5